The most outstanding
Grupo SURA posted USD 595 million in YTD net income at the end of Q3 2025
Publicado el 13 November 2025
Grupo SURA agreed to sell its stake in ARUS
Publicado el 24 November 2025
Grupo SURA moves forward with its debt management strategy with two credit operations for COP 1.8 trillion
Publicado el 09 September 2025
News Center
VaxThera, a SURA company, inaugurated its vaccine packaging and finishing plant in Colombia
Publicado el 15 May 2024
Grupo SURA has appointed a new Chief Executive Officer
Publicado el 25 April 2024
Year-end report
Publicado el 10 April 2024
Board of Directors Appointments for the Period 2024 - 2026
Publicado el 02 April 2024
Signing of a material financing agreement on the part of the subsidiary SURA Asset Management
Publicado el 26 March 2024